Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clonidine with Morphine for Vaso-occlusive Crisis in Sickle Cell Disease
NCT05848531Phase 4Unknown
- Sponsor
- Saint-Pierre University Hospital
- Start
- Apr 2023
- Primary completion
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of clonidine in vaso-occlusive crisis (VOC) (2 arms), sponsored by Saint-Pierre University Hospital. Primary endpoint: Morphine Consumption up to 2 weeks. Status: unknown.
02
Drugs
clonidine
03
Conditions
vaso-occlusive crisis (VOC)
Beyond the preview
Go deeper on NCT05848531.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05848531.